Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-20-002175

SVP, Chief Financial Officer gave up 4,508 shares (to pay taxes)

  • SVP, Chief Financial Officer acquired 11,392 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Stelzer Laurie · SVP, Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-22 Exercise or conversion : show line 1 in the form +11,392 120,675 D
2020-02-22 Shares withheld for taxes : show line 2 in the form −4,508 $21.83 $98,410 116,167 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Underlying Owned after D/I
2020-02-22 Exercise or conversion : show line 3 in the form Restricted Stock Units −11,392 $0.00 11,392 11,392 D
Loading xslF345X03/edgar.xml…